ロード中...
Effect of Levodopa‐carbidopa Intestinal Gel on Non‐motor Symptoms in Patients with Advanced Parkinson's Disease
BACKGROUND: Levodopa‐carbidopa intestinal gel (LCIG; carbidopa‐levodopa enteral suspension in the United States), delivered via percutaneous gastrojejunostomy (PEG‐J) and titrated in the inpatient setting, is an established treatment option for advanced Parkinson's disease (PD) patients with mo...
保存先:
| 出版年: | Mov Disord Clin Pract |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5724683/ https://ncbi.nlm.nih.gov/pubmed/29242809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12526 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|